CD19 and B-cell chronic lymphocytic leukemia: The cytotoxic activity of ITK-KO CD19-CAR-T cells was further assessed in vitro against a panel of cell line models of B cell malignancy (including two CLL cell lines expressing CD19 — MEC1 and HG3 — and the Raji cell line, derived from Burkitt lymphoma).